Expression and activity of mTOR and its substrates in different cell cycle phases and in oral squamous cell carcinomas of different malignant grade

Cell Biochemistry and Function

Volumn 25, Issue 1, 2007, Pages 45-53

  Liu, Yi ^a   Hidayat, Sujuta ^a   Su, Wen Hui ^a   Deng, Xin ^a   Yu, Da Hai ^a   Yu, Bing Zhi ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

4EBP 1; Cell cycle phase; Hela cells; mTOR; Oral squamous carcinoma; p70s6K

Indexed keywords

INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA;

ARTICLE; CANCER GRADING; CARCINOGENESIS; CELL CYCLE PHASE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MOUTH NEOPLASMS; NEOPLASM STAGING; PHOSPHOPROTEINS; PROTEIN KINASES; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA, MESSENGER; SUBSTRATE SPECIFICITY;

EUKARYOTA; MAMMALIA;

EID: 33846318172     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1332     Document Type: Article

References (18)

1. Schmelzle T, Hall MN. TOR, a central controller of cell growth. Cell 2000; 103: 253-262.
2. Keith CT, Schreiber SL. PIK-related kinases: DNA repairs, recombination, and cell cycle checkpoint. Science 1995; 270: 50-51.
3. Thomas G, Hall MN. TOR signaling and control of cell growth. Curr Opin Cell Biol 1977; 9: 782-787.
4. Powell JD, Bruniquel D, Schwartz RH. TOR engagement in the absence of cell cycle progression leads to T cell anergy independent of p27 (kip1). Eur J Immunol 2001; 31: 3737-3746.
5. Wang X, Anne Beugnet, Mirei Murakami, Shinya Yamanaka, Christopher G Proud. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins. Mol Cell Biol 2005; 25: 2558-2572.
6. Markwell MA, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978; 87: 206-210.
7. Kim JE, Chen Jie. Cytoplasmic-nuclear shuttling of FKBP12-rapamycin- associated protein is involved in rapamycin-sensitive signaling and translation initation. Proc Natl Acad Sci USA 2000; 97: 14340-14345.
8. Fingar DC, Richardson CJ, Tee AR, Cheatham L, Tsou C, Blenis J. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4EBP-1/eukaryotic translation initiation factor 4E. Mol Cell Bio 2004; 24: 200-216.
9. Montagne J, Stewart MJ, Stocker H, Hafen E, Kozma SC, Thomas G. Drosophila S6 kinase: A regulator of cell size. Science 1999; 285: 2126-2129.
10. Diane CF, Celeste JR, Andrew RT, Lynn C, Christina T, John B. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4EBP-1/eukaryotic translation initiation factor 4E. Mol Cell Biol 2004; 24: 200-216.
11. Jefferies HB, Fumagalli S, Dennis PB, Reinhard C. Rapamycin suppresses 5′ TOP rnRNA translation inhibition of p70S6K. EMBO J 1997; 16: 3693-3704.
12. Dilling MB, Germain GS, Dudkin L, Jayaraman AL, Zhang X. 4E-binding proteins, the supressors of eukaryotic initiation factor 4E, are down-regulated in cells with acquired or intrinsic resistance to rapamycin. J Biol Chem 2002; 277: 13907-13917.
13. isotani S, Hara K, Yonezawa K. Immunopurified mammalian target of rapamycin phosphorylates and activates p70S6 kinase a in vitro. J Biol Chem 1999; 274: 34493-34498.
14. Garber K. Rapamycin's resurrection: a new way to target the cancer cell cycle. J Natl Cancer Inst 2001; 93: 1517-1519.
15. Mepherron AC, Lawler AM, Lee SL. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387: 83-90.
16. Conlon I, Raff M. Size control in animal development. Cell 1999; 96: 235-244.
17. Liu Yi, Tian Yu-lou, Yu Bing-zhi. The activity of M-phase promoting factor in oral normal tissue and tumor. Chin J Stomatol 2002; 37: 123-125.
18. Gao N, Zhang Z, Jiang BH, et al. Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer. Biochem Biophys Res Commun 2003; 310: 1124-1132.